TSHA Taysha Gene Therapies PE ratio, current and historical analysis

  1. Stocks
  2. Healthcare
  3. NASDAQ: TSHA
  4. PE Ratio

The current PE ratio of TSHA cannot be calculated, as the latest EPS of -$0.36 is negative. The most recent PE ratio recorded for Taysha Gene Therapies was 3.19 in September 2024.

TSHA PE ratio history

How has TSHA's PE ratio performed in the past
Today
N/A
Average
N/A
Median
N/A
Minimum
N/A
Maximum
N/A

Taysha Gene Therapies PE ratio by year

Year PE ratio PE change Price EPS
2024 N/A N/A $1.73 -$0.36
2023 N/A N/A $1.77 -$0.96
2022 N/A N/A $2.26 -$3.78
2021 N/A N/A $11.65 -$4.64
2020 N/A N/A $26.54 -$3.4

Taysha Gene Therapies PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Dec 2024 N/A N/A $1.73 -$0.36
Sep 2024 3.19 N/A $2.01 $0.63
Jun 2024 N/A N/A $2.24 -$0.2
Mar 2024 N/A N/A $2.87 -$0.49
Dec 2023 N/A N/A $1.77 -$0.96
Sep 2023 N/A N/A $3.16 -$2.58
Jun 2023 N/A N/A $0.66 -$2.3
Mar 2023 N/A N/A $0.8 -$2.77
Dec 2022 N/A N/A $2.26 -$3.78
Sep 2022 N/A N/A $1.93 -$4.15
Jun 2022 N/A N/A $3.72 -$4.85
Mar 2022 N/A N/A $6.52 -$5.09
Dec 2021 N/A N/A $11.65 -$4.64
Sep 2021 N/A N/A $18.62 -$2.98
Jun 2021 N/A N/A $21.2 -$2.91

TSHA average PE ratio chart

What is the average PE ratio of TSHA for the past years
3-year avg
N/A
5-year avg
N/A
10-year avg
N/A
15-year avg
N/A

TSHA PE vs peers

What is TSHA's PE ratio compared to its peers
Stock name PE ratio Market cap
OLMA Olema Pharmaceuticals Inc N/A $230.28M
OMER Omeros Corp N/A $432M
ONVO Organovo Holdings Inc N/A $3.16M
ORIC Oric Pharmaceuticals Inc N/A $369.69M
ORMP Oramed Pharmaceuticals Inc N/A $89.46M
TSHA Taysha Gene Therapies Inc N/A $262.4M

Frequently asked questions

What is Taysha Gene Therapies's PE ratio?

The current price to earnings ratio of TSHA cannot be determined, as its EPS of -$0.36 is negative.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.